SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 11:15 a.m. PT.
Read more at globenewswire.comORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ORIC PHARMACEUTICALS INC
NASDAQ:ORIC (2/11/2025, 8:00:01 PM)
After market: 9.9 +0.05 (+0.51%)9.85
-1.38 (-12.29%)
ORIC Latest News and Analysis
16 hours ago - ChartmillTuesday's session: gap up and gap down stocksLet's have a look at the gap up and gap down stocks in today's session.
